Lycopodium Limited
LYOPF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3.1% | 6.4% | 41.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 92.1% | 90.7% | 24.8% | 18.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 20.3% | 22.2% | 21.1% | 20% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 12.6% | 14.7% | 14.4% | 11.9% |
| EPS Diluted | 1.06 | 1.28 | 1.18 | 0.68 |
| % Growth | -17.2% | 8.5% | 73.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |